Trial
NCT02531321
Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Southern California
Collaborators
—
Condition
Contraception
Intervention
Levonorgestrel and Ethinyl Estradiol
Why stopped
Difficulty recruiting
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-31